Encapsulation & Solid Dose

Microencapsulation

Wrapping individual particles or droplets of an active in a thin shell — to mask taste, protect a fragile ingredient, time its release, or turn a liquid into a powder. The active becomes a payload, and the claim is only as good as the efficiency behind it.

Where microencapsulation sits in the line — the family of encapsulation and solid-dose forms.See the other solid-dose technologies Microencapsulation’s routes — spray drying, fluid-bed coating — are borrowed from particle engineering.See the drying & particle technologies The larger encapsulated forms — two-piece and soft capsules — that carry the same protect-and-deliver idea at a bigger scale.Browse capsule technologies
What it is

A shell around each particle — built for one functional job.

Microencapsulation coats individual particles or droplets of an active in a thin protective shell at the micro scale. It’s done for a specific reason — to mask a bitter taste, protect a sensitive ingredient from air or moisture, control where and when the active releases, or convert a liquid into a free-flowing powder. The active stops being a loose ingredient and becomes a payload inside an engineered microcapsule.

It isn’t one machine but a family of routes — spray drying, coacervation, fluid-bed coating, extrusion — chosen to fit the goal, the core, and the wall material. The route is a means; the functional claim is the end.

The levers are the wall material and its thickness, the core-to-wall ratio, the particle size, and the encapsulation route. Together they set two things that matter more than any other: how much active actually ends up inside a shell, and how it releases once it’s there.

The core is dispersed in the wall system — an emulsion, suspension, or melt — encapsulated by the chosen route, then hardened or dried and sized into a free-flowing powder with a defined payload and release profile.

Process flow
1

Core (active) and wall material — polymer, lipid, gum, or carbohydrate — selected for the goal

2

Core dispersed in the wall system (emulsion, suspension, or melt)

3

Encapsulation by the chosen route — spray drying, coacervation, fluid-bed coating, or extrusion

4

Microcapsules hardened or dried and sized

Free-flowing microcapsules with a defined payload and release profile

The leversWall material and thickness, core-to-wall ratio, particle size, and the encapsulation route.
Why it matters

The functional claim is only as real as the efficiency behind it.

Microencapsulation is always chosen for a claim — protect, mask, or time the release. And that claim rests on two measurable things: encapsulation efficiency, meaning how much active is actually encapsulated versus left free, and the release profile, meaning whether the payload comes out where and when it should. If those aren’t controlled, the claim is a story, not a property.

A poorly run process betrays the claim quietly. Free, unencapsulated active undermines a taste-mask or a stability promise; an inconsistent release profile means the timing varies dose to dose; and a payload can still degrade if the shell doesn’t actually protect it. The discipline is measuring efficiency and payload per batch, characterizing release and proving it reproducible, and showing the encapsulated form really outlasts the bare active.

21 CFR 211 · drugFor a drug, microencapsulation is a validated process under cGMP — encapsulation efficiency, payload, and particle size controlled in-process, and drug release tested against a defined profile before the lot is released.
21 CFR 111 · supplementFor a supplement, the encapsulation-efficiency, payload, and particle-size specs live in the master manufacturing record, and each batch record verifies the finished microcapsules met them.
USP <905> · uniformityOnce the microcapsules are dosed into a capsule or tablet, USP <905> sets the dose-to-dose uniformity the finished unit must hold — the acceptance-value test the payload has to pass.
USP <711> · dissolutionUSP <711> is where the release claim is proven — a dissolution profile, multi-point for modified release, showing the payload comes out where and when the label says.

The governing rule follows the product class; encapsulation efficiency, payload, and a characterized release profile anchor the rest.

How it compares

Why a maker microencapsulates — and what they trade.

Microencapsulation protects at the particle level. Knowing what it was chosen over tells you what the bare active couldn’t do.

vs.

Direct use of the active

Using the active as-is is cheaper and simpler, with no added process.

The tradeEncapsulation buys protection, taste-masking, or controlled release the bare active can’t deliver — at the cost of process and verification.
vs.

Tablet coating (macro)

Coating a finished tablet protects the whole dosage unit at once.

The tradeMicroencapsulation protects individual particles, so the protection survives blending and compression — a coated tablet’s doesn’t.
vs.

Softgel / liquid delivery

A softgel or liquid protects the active by sealing it in a container.

The tradeMicroencapsulation protects at the particle level inside a dry product — no container required.
Where it tends to go wrong

The gaps a reviewer looks for on a microencapsulated active.

None of these are exotic. They’re the quiet places a microencapsulation drifts away from its own claim — recognizable the moment you’ve run one.

Encapsulation efficiency and payload aren’t measured, so the protective claim is unverified.

The release profile isn’t characterized, or isn’t reproducible batch to batch.

Free, unencapsulated active runs uncontrolled, undermining the taste-mask or stability claim.

Wall-material grade and particle size aren’t specified, so the shell itself varies.

Protection lost downstream is untested — microcapsules ruptured during blending or compression.

Stability of the encapsulated active isn’t demonstrated against the bare-active baseline.

If this is your operation

Six things to check against your own records.

Not an audit — a read you can run yourself before anyone else does. Pull one recent batch and walk it.

01

Ask how encapsulation efficiency and payload are measured per batch.

02

Check whether the release profile is characterized and reproducible.

03

Look at how free, unencapsulated active is controlled.

04

Confirm wall-material grade and microcapsule size specs.

05

Review whether downstream processing ruptures the capsules.

06

Ask for stability data on the encapsulated form versus the bare active.

Applications

The same operation, across very different payloads.

The route changes with the goal — the discipline never does: prove the efficiency, characterize the release, keep the shell intact to the finished product.

Pharma

Taste-masking & controlled release

Coating bitter actives so they’re palatable, and engineering sustained- or delayed-release particles where the shell sets the timing of the dose.

Supplement

Probiotics, omega-3s & reactive minerals

Shielding probiotics through processing and gastric transit, protecting omega-3s from oxidation, and coating reactive minerals so they don’t degrade a blend.

Food & beverage

Flavors, acids & fortificants

Encapsulating volatile flavors, leavening acids, and added vitamins and minerals so they survive processing and release at the right moment.

Cosmetic

Actives & fragrance

Microencapsulating sensitive actives and fragrance for stability and timed or triggered release in skincare and color products.